| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | General Counsel
1 company
Christine Ring is Chief Legal Officer at NRIX. From February 2021 to October 2026, the filings on record show 0 open-market purchases and 63 sales. Christine Ring's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $396K at current prices.
Our model assigns Christine Ring a strong insider score of 75/100, based on 59 past trades. Over a 12-month horizon, 86.0% of those trades were profitable, with an average 12-month return of +27.5%.
The NRIX filings lean toward selling, a net 304,318 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 10, 2021 | NRIX Nurix Therapeutics, Inc. | General Counsel | Sale+OE | 1,200 | $32.38 | $38,856.00 | -48.3% | -42.7% | -59.0% | |
| Oct 27, 2021 | NRIX Nurix Therapeutics, Inc. | General Counsel | Sale+OE | 800 | $35.25 | $28,200.00 | -38.4% | -42.6% | -64.0% | |
| Oct 11, 2021 | NRIX Nurix Therapeutics, Inc. | General Counsel | Sale+OE | 1,200 | $27.36 | $32,832.00 | -48.3% | -17.0% | -60.6% | |
| Sep 10, 2021 | NRIX Nurix Therapeutics, Inc. | General Counsel | Sale+OE | 2,000 | $35.93 | $71,860.17 | -60.9% | -19.2% | -55.7% | |
| Sep 7, 2021 | NRIX Nurix Therapeutics, Inc. | General Counsel | Sale+OE | 3,200 | $35.25 | $112,800.00 | -71.3% | -21.2% | -54.2% | |
| Aug 10, 2021 | NRIX Nurix Therapeutics, Inc. | General Counsel | Sale+OE | 1,200 | $29.87 | $35,844.96 | -59.9% | +10.2% | -34.7% | |
| Jul 20, 2021 | NRIX Nurix Therapeutics, Inc. | General Counsel | Sale+OE | 1,200 | $27.00 | $32,400.00 | -59.9% | -1.2% | -40.9% | |
| Jun 10, 2021 | NRIX Nurix Therapeutics, Inc. | General Counsel | Sale+OE | 1,200 | $29.40 | $35,282.00 | -59.9% | +20.6% | -65.4% | |
| May 10, 2021 | NRIX Nurix Therapeutics, Inc. | General Counsel | Sale+OE | 1,200 | $27.00 | $32,400.00 | -59.9% | +15.2% | -64.8% | |
| Apr 28, 2021 | NRIX Nurix Therapeutics, Inc. | General Counsel | Sale+OE | 800 | $35.25 | $28,200.00 | -49.8% | -16.5% | -67.6% |